PCV19 COMPARATIVE RISK OF HEART FAILURE HOSPITALIZATIONS ASSOCIATED WITH DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS: A POPULATION-BASED COHORT STUDY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.744
https://www.valueinhealthjournal.com/article/S1098-3015(19)33122-5/fulltext
Title :
PCV19 COMPARATIVE RISK OF HEART FAILURE HOSPITALIZATIONS ASSOCIATED WITH DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS: A POPULATION-BASED COHORT STUDY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33122-5&doi=10.1016/j.jval.2019.09.744
First page :
Section Title :
Open access? :
No
Section Order :
10649